{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:09:11Z","timestamp":1792804151637,"version":"4.5.0"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.nbd.2025.107159","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T23:02:46Z","timestamp":1761433366000},"page":"107159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Bidirectional relationship between mitochondrial dysfunction and dysregulated lipid metabolism in Multiple Sclerosis: potential mechanisms and therapeutic implications"],"prefix":"10.1016","volume":"217","author":[{"given":"Tian","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Tin","family":"Fok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehao","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yuan","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac Oluwatobi","family":"Akefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schweitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.107159_bb0005","article-title":"Role of vitamin D and Omega-3 fatty acids in improving HDL biogenesis among multiple sclerosis patients via orchestrating CHROME\/APOA1-AS\/ABCA1\/APOA1 milieu","volume":"110007","author":"Abd-Elmawla","year":"2025","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.nbd.2025.107159_bb0010","doi-asserted-by":"crossref","unstructured":"Akefe IO, Osborne SL, Matthews B, Wallis TP, Meunier FA (2023) Lipids and secretory vesicle exocytosis. In: molecular mechanisms of neurotransmitter release, Wang Z.-W. (ed.) pp. 357-397.","DOI":"10.1007\/978-3-031-34229-5_14"},{"key":"10.1016\/j.nbd.2025.107159_bb0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s44318-024-00030-7","article-title":"The DDHD2-STXBP1 interaction mediates long-term memory via generation of saturated free fatty acids","volume":"43","author":"Akefe","year":"2024","journal-title":"EMBO J."},{"issue":"7","key":"10.1016\/j.nbd.2025.107159_bb0020","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/1028415X.2019.1659560","article-title":"Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: A systematic review","volume":"24","author":"AlAmmar","year":"2021","journal-title":"Nutr. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0030","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1186\/s12967-023-04637-y","article-title":"Elevated phospholipids and acylcarnitines C4 and C5 in cerebrospinal fluid distinguish viral CNS infections from autoimmune neuroinflammation","volume":"21","author":"Al-Mekhlafi","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.nbd.2025.107159_bb0035","article-title":"Medication targeting to subcellular organelles: emphasizing mitochondria as a therapeutic marvel\u2014current situation and future prospects","volume":"114647","author":"Alzhrani","year":"2025","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.nbd.2025.107159_bb0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/glia.24631","article-title":"Neuroprotective effect of neuron-specific deletion of the C16 ceramide synthetic enzymes in an animal model of multiple sclerosis","volume":"73","author":"Amatruda","year":"2025","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0045","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/ijms26010380","article-title":"Plant secondary metabolites as modulators of mitochondrial health: an overview of their anti-oxidant, anti-apoptotic, and Mitophagic mechanisms","volume":"26","author":"Anchimowicz","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.107159_bb0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.msard.2019.03.006","article-title":"Metabolome-based signature of disease pathology in MS","volume":"31","author":"Andersen","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.nbd.2025.107159_bb0055","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.nbd.2025.107159_bb0060","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/med.21712","article-title":"Mitochondria and lipid peroxidation in the mechanism of neurodegeneration: finding ways for prevention","volume":"41","author":"Angelova","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"6","key":"10.1016\/j.nbd.2025.107159_bb0065","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.cmet.2020.11.007","article-title":"SCENITH: a flow cytometry-based method to functionally profile energy metabolism with single-cell resolution","volume":"32","author":"Arg\u00fcello","year":"2020","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.nbd.2025.107159_bb0070","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.3390\/nu13103661","article-title":"The effects of specific omega-3 and omega-6 polyunsaturated fatty acids and antioxidant vitamins on gait and functional capacity parameters in patients with relapsing-remitting multiple sclerosis","volume":"13","author":"Aristotelous","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.nbd.2025.107159_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102838","article-title":"Regulation and function of the mammalian tricarboxylic acid cycle","volume":"299","author":"Arnold","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.nbd.2025.107159_bb0080","doi-asserted-by":"crossref","first-page":"10045","DOI":"10.1007\/s12035-025-04868-8","article-title":"Epigenetic and mitochondrial metabolic dysfunction in multiple sclerosis: A review of herbal drug approaches and current clinical trials","volume":"62","author":"Ashwani","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.nbd.2025.107159_bb0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/metabo11030151","article-title":"Metabolomics and Lipidomics: expanding the molecular landscape of exercise biology","volume":"11","author":"Belhaj","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.nbd.2025.107159_bb0090","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.addr.2020.01.004","article-title":"Fatty acid metabolism in the progression and resolution of CNS disorders","volume":"159","author":"Bogie","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.nbd.2025.107159_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113065","article-title":"Neuroimmunological characterisation of a mouse model of primary progressive experimental autoimmune encephalomyelitis and effects of immunosuppressive or neuroprotective strategies on disease evolution","volume":"322","author":"Buonvicino","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2025.107159_bb0100","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ebiom.2019.03.087","article-title":"Body mass index in multiple sclerosis modulates ceramide-induced DNA methylation and disease course","volume":"43","author":"Castro","year":"2019","journal-title":"eBioMedicine"},{"issue":"7","key":"10.1016\/j.nbd.2025.107159_bb0105","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2023.03.008","article-title":"Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting","volume":"186","author":"Charabati","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2025.107159_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103582","article-title":"A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models","volume":"72","author":"Cheng","year":"2021","journal-title":"eBioMedicine"},{"key":"10.1016\/j.nbd.2025.107159_bb0115","series-title":"GeneReviews\u00ae","article-title":"Primary mitochondrial disorders overview","author":"Chinnery","year":"1993"},{"issue":"20","key":"10.1016\/j.nbd.2025.107159_bb0120","doi-asserted-by":"crossref","first-page":"10909","DOI":"10.3390\/ijms252010909","article-title":"Obesity control and supplementary nutraceuticals as cofactors of brain plasticity in multiple sclerosis populations","volume":"25","author":"Cium\u0103rnean","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.107159_bb0125","article-title":"Levels of leukocyte oxidative DNA damage (8-OHdG), serum coenzyme Q10 and lipid peroxidation in the formation attacks of patients with multiple sclerosis. Journal of cellular neuroscience and oxidative","volume":"9(1), Article 1","author":"\u00c7okluk","year":"2017","journal-title":"Stress"},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/imm.13870","article-title":"Sphingosine-1-phosphate Signalling inhibition suppresses Th1-like Treg generation by reversing mitochondrial uncoupling","volume":"174","author":"Coulombeau","year":"2025","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jamaneurol.2020.2950","article-title":"Efficacy and safety of 2 fingolimod doses vs glatiramer acetate for the treatment of patients with relapsing-remitting multiple sclerosis: A randomized clinical trial","volume":"78","author":"Cree","year":"2021","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.nbd.2025.107159_bb0140","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1177\/13524585221083194","article-title":"Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: analysis of EXPAND core and extension data up to> 5 years","volume":"28","author":"Cree","year":"2022","journal-title":"Mult. Scler. J."},{"issue":"12","key":"10.1016\/j.nbd.2025.107159_bb0145","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1177\/13524585221102584","article-title":"Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: up to 5 years of follow-up in the DAYBREAK open-label extension trial","volume":"28","author":"Cree","year":"2022","journal-title":"Mult. Scler. J."},{"issue":"13","key":"10.1016\/j.nbd.2025.107159_bb0150","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3390\/foods14132193","article-title":"Nutraceutical strategies for targeting mitochondrial dysfunction in neurodegenerative diseases","volume":"14","author":"Dav\u00ec","year":"2025","journal-title":"Foods"},{"issue":"2","key":"10.1016\/j.nbd.2025.107159_bb0155","first-page":"37","volume":"8","author":"de Barcelos","year":"2019","journal-title":"Mitochondrial Dysfunction and Multiple Sclerosis. Biology"},{"issue":"4","key":"10.1016\/j.nbd.2025.107159_bb0160","doi-asserted-by":"crossref","first-page":"Article 4","DOI":"10.3390\/biomedicines8040085","article-title":"PBMC of multiple sclerosis patients show deregulation of OPA1 processing associated with increased ROS and PHB2 protein levels","volume":"8","author":"De Rasmo","year":"2020","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.nbd.2025.107159_bb0165","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/ni.3269","article-title":"Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants","volume":"16","author":"De Rosa","year":"2015","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.nbd.2025.107159_bb0170","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s40265-021-01510-4","article-title":"Targeting AMPK by statins: A potential therapeutic approach","volume":"81","author":"Dehnavi","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.nbd.2025.107159_bb0175","series-title":"Molecular Pharmacodynamics of New Oral Drugs Used in the Treatment of Multiple Sclerosis","first-page":"555","author":"di Nuzzo","year":"2014"},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0180","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11010-009-0165-7","article-title":"QGP-1 cells release 5-HT via TRPA1 activation; a model of human enterochromaffin cells","volume":"331","author":"Doihara","year":"2009","journal-title":"Mol. Cell. Biochem."},{"issue":"11","key":"10.1016\/j.nbd.2025.107159_bb0185","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.3390\/biology11111633","article-title":"Mitochondrial impairments in peripheral blood mononuclear cells of multiple sclerosis patients","volume":"11","author":"Dom\u00ednguez-Mozo","year":"2022","journal-title":"Biology"},{"issue":"6","key":"10.1016\/j.nbd.2025.107159_bb0190","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nm.2389","article-title":"Identification of T helper type 1\u2013like, Foxp3+ regulatory T cells in human autoimmune disease","volume":"17","author":"Dominguez-Villar","year":"2011","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.nbd.2025.107159_bb0195","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: A review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"issue":"8","key":"10.1016\/j.nbd.2025.107159_bb0200","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jamaneurol.2018.0611","article-title":"Use of vitamins and dietary supplements by patients with multiple sclerosis: A review","volume":"75","author":"Evans","year":"2018","journal-title":"JAMA Neurol."},{"issue":"12","key":"10.1016\/j.nbd.2025.107159_bb0205","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41573-019-0035-2","article-title":"Progressive multiple sclerosis: from pathophysiology to therapeutic strategies","volume":"18","author":"Faissner","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.nbd.2025.107159_bb0210","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.tem.2021.01.006","article-title":"Cardiolipin, mitochondria, and neurological disease","volume":"32","author":"Falabella","year":"2021","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1874609809666160921113706","article-title":"Cellular and molecular mechanisms of action of mitochondria-targeted antioxidants","volume":"10","author":"Feniouk","year":"2017","journal-title":"Curr. Aging Sci."},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0220","article-title":"Therapeutic effect of the mitochondria-targeted antioxidant SkQ1 on the culture model of multiple sclerosis","volume":"2019","author":"Fetisova","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.nbd.2025.107159_bb0225","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.3390\/ijms24043739","article-title":"Mitochondria-targeted antioxidants, an innovative class of antioxidant compounds for neurodegenerative diseases: perspectives and limitations","volume":"24","author":"Fields","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.nbd.2025.107159_bb0230","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1177\/1352458520971816","article-title":"Serum ceramide levels are altered in multiple sclerosis","volume":"27","author":"Filippatou","year":"2021","journal-title":"Multiple Sclerosis (Houndmills, Basingstoke, England)"},{"issue":"4","key":"10.1016\/j.nbd.2025.107159_bb0235","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrneurol.2014.37","article-title":"Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis","volume":"10","author":"Friese","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0240","doi-asserted-by":"crossref","first-page":"17026","DOI":"10.1038\/s41598-018-35232-7","article-title":"Lipoprotein markers associated with disability from multiple sclerosis","volume":"8","author":"Gafson","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.107159_bb0245","doi-asserted-by":"crossref","unstructured":"Gharighnia, S., Omidi, Ameneh, Ragerdi Kashani, Iraj, Sepand, Mohammad Reza, & and Pour Beiranvand, S. (2024). Ameliorative effects of acetyl-L-carnitine on corpus callosum and functional recovery in demyelinated mouse model. Int. J. Neurosci., 134(4), 409\u2013419. doi:https:\/\/doi.org\/10.1080\/00207454.2022.2107515.","DOI":"10.1080\/00207454.2022.2107515"},{"key":"10.1016\/j.nbd.2025.107159_bb0250","doi-asserted-by":"crossref","unstructured":"Giovannoni, G., & Mathews, J. (2022). Cladribine Tablets for Relapsing\u2013Remitting Multiple Sclerosis: A Clinician's Review. Neurology and Therapy, 11(2), 571\u2013595. doi:https:\/\/doi.org\/10.1007\/s40120-022-00339-7.","DOI":"10.1007\/s40120-022-00339-7"},{"issue":"4","key":"10.1016\/j.nbd.2025.107159_bb0255","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/jnc.15133","article-title":"The role of sphingolipids in myelination and myelin stability and their involvement in childhood and adult demyelinating disorders","volume":"156","author":"Giussani","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2025.107159_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.541040","article-title":"The functional impact of mitochondrial structure across subcellular scales","volume":"11","author":"Glancy","year":"2020","journal-title":"Front. Physiol."},{"issue":"51","key":"10.1016\/j.nbd.2025.107159_bb0265","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031802","article-title":"Identification of ferroptosis-related gene signatures associated with multiple sclerosis using weighted gene co-expression network analysis","volume":"101","author":"Gu","year":"2022","journal-title":"Medicine"},{"issue":"48","key":"10.1016\/j.nbd.2025.107159_bb0270","doi-asserted-by":"crossref","first-page":"24880","DOI":"10.1074\/jbc.M116.736793","article-title":"StarD7 protein deficiency adversely affects the phosphatidylcholine composition, respiratory activity, and cristae structure of mitochondria","volume":"291","author":"Horibata","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.nbd.2025.107159_bb0275","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1093\/hmg\/ddaa282","article-title":"Dimethyl fumarate dose-dependently increases mitochondrial gene expression and function in muscle and brain of Friedreich\u2019s ataxia model mice","volume":"29","author":"Hui","year":"2020","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.nbd.2025.107159_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165638","article-title":"AMPK activation prevents and reverses drug-induced mitochondrial and hepatocyte injury by promoting mitochondrial fusion and function","volume":"11","author":"Kang","year":"2016","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.nbd.2025.107159_bb0285","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/jamaneurol.2021.0405","article-title":"Ponesimod compared with teriflunomide in patients with relapsing multiple sclerosis in the active-comparator phase 3 OPTIMUM study: A randomized clinical trial","volume":"78","author":"Kappos","year":"2021","journal-title":"JAMA Neurol."},{"issue":"7","key":"10.1016\/j.nbd.2025.107159_bb0290","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1080\/1028415X.2024.2425649","article-title":"Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: A double-blind, randomized placebo-controlled trial","volume":"28","author":"Keramatzadeh","year":"2025","journal-title":"Nutr. Neurosci."},{"issue":"13","key":"10.1016\/j.nbd.2025.107159_bb0295","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.3390\/jcm12134274","article-title":"Cellular and molecular evidence of multiple sclerosis diagnosis and treatment challenges","volume":"12","author":"Khan","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.nbd.2025.107159_bb0300","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuroscience.2024.04.004","article-title":"Immune system dysregulation in the progression of multiple sclerosis: molecular insights and therapeutic implications","volume":"548","author":"Khan","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2025.107159_bb0305","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2174\/0118715303325979241206115417","article-title":"The polygenic nature of multiple sclerosis: genetic variants, immunological modulation, and environmental connections","volume":"25","author":"Khan","year":"2025","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.nbd.2025.107159_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108432","article-title":"Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis","volume":"246","author":"Kihara","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0315","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/brain\/awh310","article-title":"Neuropathology of white matter disease in Leber\u2019s hereditary optic neuropathy","volume":"128","author":"Kov\u00e1cs","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.107159_bb0320","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.metabol.2017.08.011","article-title":"Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration","volume":"77","author":"La Rocca","year":"2017","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.nbd.2025.107159_bb0325","article-title":"Metabolomics of multiple sclerosis lesions demonstrates lipid changes linked to alterations in transcriptomics-based cellular profiles","volume":"11","author":"Ladakis","year":"2024","journal-title":"Neurology: Neuroimmunology & Neuroinflammation"},{"issue":"3","key":"10.1016\/j.nbd.2025.107159_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.165630","article-title":"High fat diet consumption results in mitochondrial dysfunction, oxidative stress, and oligodendrocyte loss in the central nervous system","volume":"1866","author":"Langley","year":"2020","journal-title":"Biochimica Et Biophysica Acta. Molecular Basis of Disease"},{"issue":"9","key":"10.1016\/j.nbd.2025.107159_bb0335","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1111\/ene.15360","article-title":"The contribution of neuropathology to multiple sclerosis research","volume":"29","author":"Lassmann","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"9","key":"10.1016\/j.nbd.2025.107159_bb0340","doi-asserted-by":"crossref","first-page":"Article 9","DOI":"10.3390\/ijms130911783","article-title":"Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via Fumaric acid esters","volume":"13","author":"Lee","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0345","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/glia.24629","article-title":"The antipsychotic chlorpromazine reduces neuroinflammation by inhibiting microglial voltage-gated potassium channels","volume":"73","author":"Lee","year":"2025","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.nbd.2025.107159_bb0350","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1194\/jlr.C400005-JLR200","article-title":"Levels of 7-oxocholesterol in cerebrospinal fluid are more than one thousand times lower than reported in multiple sclerosis","volume":"46","author":"Leoni","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2025.107159_bb0355","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jsbmb.2016.03.029","volume":"169","author":"Leoni","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0360","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12851","article-title":"Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis","volume":"49","author":"Licht-Mayer","year":"2023","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0365","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/ijms25010261","article-title":"Investigating the Mitoprotective effects of S1P receptor modulators ex vivo using a novel semi-automated live imaging set-up","volume":"25","author":"Ludwig","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"42","key":"10.1016\/j.nbd.2025.107159_bb0370","doi-asserted-by":"crossref","first-page":"10185","DOI":"10.1523\/JNEUROSCI.1378-17.2017","article-title":"Mitochondrial DNA double-Strand breaks in oligodendrocytes cause demyelination, axonal injury, and CNS inflammation","volume":"37","author":"Madsen","year":"2017","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0375","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbadis.2009.07.002","article-title":"Is multiple sclerosis a mitochondrial disease?","volume":"1802","author":"Mao","year":"2010","journal-title":"Biochimica et Biophysica Acta (BBA) \u2013 Mol. Basis Dis."},{"key":"10.1016\/j.nbd.2025.107159_bb0380","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2019.04.022","article-title":"The S1P mimetic fingolimod phosphate regulates mitochondrial oxidative stress in neuronal cells","volume":"137","author":"Mart\u00edn-Monta\u00f1ez","year":"2019","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0385","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12035-024-04264-8","article-title":"Genetic contribution to medium-term disease activity in multiple sclerosis","volume":"62","author":"Mascia","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2025.107159_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2019.103417","article-title":"Glial mitochondrial function and dysfunction in health and neurodegeneration","volume":"101","author":"McAvoy","year":"2019","journal-title":"Molecular and Cellular Neuroscience"},{"issue":"33","key":"10.1016\/j.nbd.2025.107159_bb0395","doi-asserted-by":"crossref","first-page":"13525","DOI":"10.1073\/pnas.0705924104","article-title":"TRPA1 mediates formalin-induced pain","volume":"104","author":"McNamara","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"30","key":"10.1016\/j.nbd.2025.107159_bb0400","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.12998\/wjcc.v12.i30.6361","article-title":"Overview of emerging therapies for demyelinating diseases","volume":"12","author":"Medina","year":"2024","journal-title":"World J. Clin. Cases"},{"issue":"4","key":"10.1016\/j.nbd.2025.107159_bb0405","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1083\/jcb.201511036","article-title":"Metabolic regulation of mitochondrial dynamics","volume":"212","author":"Mishra","year":"2016","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.nbd.2025.107159_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234493","article-title":"Pharmacological inhibition of carnitine palmitoyl transferase 1 inhibits and reverses experimental autoimmune encephalitis in rodents","volume":"15","author":"M\u00f8rkholt","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.nbd.2025.107159_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2020.103538","article-title":"Mitochondrial damage-associated molecular patterns stimulate reactive oxygen species production in human microglia","volume":"108","author":"Nasi","year":"2020","journal-title":"Mol. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0425","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1134\/S1607672919030153","article-title":"Molecular dynamics modeling of the interaction of cationic fluorescent lipid peroxidation-sensitive probes with the mitochondrial membrane","volume":"486","author":"Nesterenko","year":"2019","journal-title":"Dokl. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.nbd.2025.107159_bb0430","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nm.2324","article-title":"A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"17","author":"Niki\u0107","year":"2011","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0435","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/10409238.2010.522975","article-title":"Roles for lysophospholipid S1P receptors in multiple sclerosis","volume":"46","author":"Noguchi","year":"2011","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.nbd.2025.107159_bb0440","doi-asserted-by":"crossref","first-page":"11313","DOI":"10.1038\/s41598-019-47906-x","article-title":"Lipid profile of cerebrospinal fluid in multiple sclerosis patients: A potential tool for diagnosis","volume":"9","author":"Nogueras","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.107159_bb0445","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.steroids.2015.02.003","article-title":"Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7\u03b2-hydroxycholesterol-, or 24(S)-hydroxycholesterol: protective effects of \u03b1-tocopherol and docosahexaenoic acid (DHA; C22:6 n-3)","volume":"99","author":"Nury","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.nbd.2025.107159_bb0450","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","article-title":"Oxidative stress in multiple sclerosis: central and peripheral mode of action","volume":"277","author":"Ohl","year":"2016","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0460","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1038\/s41467-025-60747-9","article-title":"FABP7 is increased in progressive multiple sclerosis and induces a pro-inflammatory phenotype in monocytes through a glycolytic switch","volume":"16","author":"Patel","year":"2025","journal-title":"Nat. Commun."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2025.107159_bb0465","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2005.03.015","article-title":"Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss","volume":"233","author":"Petzold","year":"2005","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.nbd.2025.107159_bb0470","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cmet.2015.08.022","article-title":"Calcineurin links mitochondrial elongation with energy metabolism","volume":"22","author":"Pfluger","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.nbd.2025.107159_bb0475","first-page":"056","volume":"33","author":"Phillips","year":"2013","journal-title":"BG-12 in multiple sclerosis."},{"issue":"10","key":"10.1016\/j.nbd.2025.107159_bb0480","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162957","article-title":"Sphingolipid desaturase DEGS1 is essential for mitochondria-associated membrane integrity","volume":"133","author":"Planas-Serra","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.nbd.2025.107159_bb0485","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1194\/jlr.RA120001022","article-title":"Distinctive sphingolipid patterns in chronic multiple sclerosis lesions","volume":"61","author":"Podbielska","year":"2020","journal-title":"J. Lipid Res."},{"issue":"14","key":"10.1016\/j.nbd.2025.107159_bb0490","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.3390\/ijms22147319","article-title":"New insights into multiple sclerosis mechanisms: lipids on the track to control inflammation and neurodegeneration","volume":"22","author":"Podbielska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.107159_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104565","article-title":"Ceramide is implicated in humoral peripheral and intrathecal autoimmune response in MS patients","volume":"71","author":"Podbielska","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0500","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12944-020-01221-x","article-title":"Lipoprotein profiling in early multiple sclerosis patients: effect of chronic inflammation?","volume":"19","author":"R\u00e1dikov\u00e1","year":"2020","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.nbd.2025.107159_bb0505","doi-asserted-by":"crossref","unstructured":"Rae-Grant, A., Day, G. S., Marrie, R. A., Rabinstein, A., Cree, B. A. C., Gronseth, G. S., Haboubi, M., Halper, J., Hosey, J. P., Jones, D. E., Lisak, R., Pelletier, D., Potrebic, S., Sitcov, C., Sommers, R., Stachowiak, J., Getchius, T. S. D., Merillat, S. A., & Pringsheim, T. (2018). Comprehensive systematic review summary: disease-modifying therapies for adults with multiple sclerosis: report of the guideline development, dissemination, and implementation Subcommittee of the American Academy of neurology. Neurology, 90(17), 789\u2013800. doi:https:\/\/doi.org\/10.1212\/WNL.0000000000005345.","DOI":"10.1212\/WNL.0000000000005345"},{"issue":"2","key":"10.1016\/j.nbd.2025.107159_bb0510","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.nbd.2025.107159_bb0515","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s40263-021-00798-w","article-title":"Sphingosine 1-phosphate receptor modulators for multiple sclerosis","volume":"35","author":"Roy","year":"2021","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0520","doi-asserted-by":"crossref","DOI":"10.1038\/srep33249","article-title":"Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis","volume":"6","author":"Sadeghian","year":"2016","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.nbd.2025.107159_bb0525","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.4049\/jimmunol.1103109","article-title":"Ceramide synthase 6 plays a critical role in the development of experimental autoimmune encephalomyelitis","volume":"188","author":"Schiffmann","year":"2012","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.nbd.2025.107159_bb0530","doi-asserted-by":"crossref","first-page":"bqz046","DOI":"10.1210\/endocr\/bqz046","article-title":"CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential","volume":"161","author":"Schlaepfer","year":"2020","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0535","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1186\/s40001-025-02981-x","article-title":"Role of vitamin D as adjuvant therapy on multiple sclerosis: an updated systematic review and meta-analysis of randomized controlled trials","volume":"30","author":"Serag","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.nbd.2025.107159_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105432","article-title":"Dimethyl fumarate and monomethyl fumarate attenuate oxidative stress and mitochondrial alterations leading to oxiapoptophagy in 158N murine oligodendrocytes treated with 7\u03b2-hydroxycholesterol","volume":"194","author":"Sghaier","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"5","key":"10.1016\/j.nbd.2025.107159_bb0545","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10715762.2019.1612891","article-title":"Biotin attenuation of oxidative stress, mitochondrial dysfunction, lipid metabolism alteration and 7\u03b2-hydroxycholesterol-induced cell death in 158N murine oligodendrocytes","volume":"53","author":"Sghaier","year":"2019","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.nbd.2025.107159_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134600","article-title":"Evolutionary genomics analysis of human nucleus-encoded mitochondrial genes: implications for the roles of energy production and metabolic pathways in the pathogenesis and pathophysiology of demyelinating diseases","volume":"715","author":"Shen","year":"2020","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0555","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/antiox10010021","article-title":"Mitochondria, oxidative stress, cAMP signalling and apoptosis: A crossroads in lymphocytes of multiple sclerosis, a possible role of nutraceutics","volume":"10","author":"Signorile","year":"2020","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.nbd.2025.107159_bb0560","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/imm.12893","article-title":"Combination therapy of lovastatin and AMP-activated protein kinase activator improves mitochondrial and peroxisomal functions and clinical disease in experimental autoimmune encephalomyelitis model","volume":"154","author":"Singh","year":"2018","journal-title":"Immunology"},{"issue":"30","key":"10.1016\/j.nbd.2025.107159_bb0565","doi-asserted-by":"crossref","first-page":"26796","DOI":"10.1074\/jbc.M200754200","article-title":"Ceramide channels increase the permeability of the mitochondrial outer membrane to small proteins","volume":"277","author":"Siskind","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.nbd.2025.107159_bb0570","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.molimm.2015.07.036","article-title":"T cell metabolic reprogramming and plasticity","volume":"68","author":"Slack","year":"2015","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0575","doi-asserted-by":"crossref","first-page":"e00119","DOI":"10.1128\/mmbr.00119-23","article-title":"Multiple sclerosis and infection: history, EBV, and the search for mechanism","volume":"89","author":"SoRelle","year":"2025","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"5","key":"10.1016\/j.nbd.2025.107159_bb0580","article-title":"Lipoic acid in secondary progressive MS: a randomized controlled pilot trial","volume":"4","author":"Spain","year":"2017","journal-title":"Neurology: Neuroimmunology & Neuroinflammation"},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0585","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-nutr-062220-112240","article-title":"The multifunctional family of mammalian fatty acid\u2013binding proteins","volume":"43","author":"Storch","year":"2023","journal-title":"Annu. Rev. Nutr."},{"issue":"17","key":"10.1016\/j.nbd.2025.107159_bb0590","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.2174\/156802611796904915","article-title":"Transient Receptor Potential A1 Modulators","volume":"11","author":"Strassmaier","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0595","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5114\/fn.2016.58911","article-title":"Histopathological comparison of Kearns-Sayre syndrome and PGC-1\u03b1-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy","volume":"54","author":"Szalardy","year":"2016","journal-title":"Folia Neuropathol."},{"issue":"23","key":"10.1016\/j.nbd.2025.107159_bb0600","doi-asserted-by":"crossref","first-page":"8402","DOI":"10.3390\/molecules27238402","article-title":"The multiple sclerosis modulatory potential of natural multi-targeting antioxidants","volume":"27","author":"Theodosis-Nobelos","year":"2022","journal-title":"Molecules"},{"issue":"16","key":"10.1016\/j.nbd.2025.107159_bb0605","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jama.2025.1604","article-title":"High-dose vitamin D in clinically isolated syndrome typical of multiple sclerosis: the D-lay MS randomized clinical trial","volume":"333","author":"Thouvenot","year":"2025","journal-title":"JAMa"},{"issue":"6","key":"10.1016\/j.nbd.2025.107159_bb0610","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.chempr.2018.02.014","article-title":"G-Quadruplex: A regulator of gene expression and its chemical targeting","volume":"4","author":"Tian","year":"2018","journal-title":"Chem"},{"issue":"6","key":"10.1016\/j.nbd.2025.107159_bb0615","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s12192-020-01131-y","article-title":"Transient receptor potential ankyrin 1 contributes to the lysophosphatidylcholine-induced oxidative stress and cytotoxicity in OLN-93 oligodendrocyte","volume":"25","author":"Tian","year":"2020","journal-title":"Cell Stress Chaperones"},{"issue":"11","key":"10.1016\/j.nbd.2025.107159_bb0620","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s40265-016-0603-2","article-title":"Sphingosine-1-phosphate (S1P) and S1P signaling pathway: therapeutic targets in autoimmunity and inflammation","volume":"76","author":"Tsai","year":"2016","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.nbd.2025.107159_bb0625","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.tibs.2010.07.003","article-title":"Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling","volume":"35","author":"Verdin","year":"2010","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0630","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12868-015-0183-1","article-title":"A lipidomic approach to the study of human CD4+ T lymphocytes in multiple sclerosis","volume":"16","author":"Vergara","year":"2015","journal-title":"BMC Neurosci."},{"issue":"9","key":"10.1016\/j.nbd.2025.107159_bb0635","doi-asserted-by":"crossref","first-page":"e2230439","DOI":"10.1001\/jamanetworkopen.2022.30439","article-title":"Effect of dimethyl fumarate vs interferon \u03b2-1a in patients with pediatric-onset multiple sclerosis: the CONNECT randomized clinical trial","volume":"5","author":"Vermersch","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"8","key":"10.1016\/j.nbd.2025.107159_bb0640","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1093\/brain\/awu139","article-title":"Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics","volume":"137","author":"Vidaurre","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.107159_bb0645","series-title":"Multiple Sclerosis (Houndmills, Basingstoke, England)","first-page":"1816","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS","volume":"vol. 26","author":"Walton","year":"2020"},{"issue":"1","key":"10.1016\/j.nbd.2025.107159_bb0650","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12974-024-03016-8","article-title":"Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis","volume":"21","author":"Wang","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"9","key":"10.1016\/j.nbd.2025.107159_bb0655","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1093\/brain\/awz201","article-title":"A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosis","volume":"142","author":"Wentling","year":"2019","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.nbd.2025.107159_bb0660","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molmed.2013.11.007","article-title":"Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis","volume":"20","author":"Witte","year":"2014","journal-title":"Trends Mol. Med."},{"issue":"11","key":"10.1016\/j.nbd.2025.107159_bb0665","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1111\/jth.13494","article-title":"Thrombomodulin-dependent protein C activation is required for mitochondrial function and myelination in the central nervous system","volume":"14","author":"Wolter","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.nbd.2025.107159_bb0670","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/antiox13040395","article-title":"The interplay between Ferroptosis and Neuroinflammation in central neurological disorders","volume":"13","author":"Xu","year":"2024","journal-title":"Antioxidants"},{"issue":"9","key":"10.1016\/j.nbd.2025.107159_bb0675","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/acn3.323","article-title":"A multiple sclerosis-like disorder in patients with OPA1 mutations","volume":"3","author":"Yu-Wai-Man","year":"2016","journal-title":"Annals of Clinical and Translational Neurology"},{"key":"10.1016\/j.nbd.2025.107159_bb0680","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jsbmb.2016.02.024","article-title":"Attenuation of 7-ketocholesterol-induced overproduction of reactive oxygen species, apoptosis, and autophagy by dimethyl fumarate on 158 N murine oligodendrocytes","volume":"169","author":"Zarrouk","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.nbd.2025.107159_bb0685","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.870957","article-title":"Integrating Lipidomics and transcriptomics reveals the crosstalk between oxidative stress and Neuroinflammation in central nervous system demyelination","volume":"14","author":"Zhao","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.nbd.2025.107159_bb0690","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.913616","article-title":"OzEAN study to collect real-world evidence of persistent use, effectiveness, and safety of ozanimod over 5 years in patients with relapsing-remitting multiple sclerosis in Germany","volume":"13","author":"Ziemssen","year":"2022","journal-title":"Front. Neurol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125003766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125003766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T22:22:27Z","timestamp":1764886947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125003766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":135,"alternative-id":["S0969996125003766"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107159","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bidirectional relationship between mitochondrial dysfunction and dysregulated lipid metabolism in Multiple Sclerosis: potential mechanisms and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107159"}}